No serious cardiac adverse events occurred. Please enable it to take advantage of the complete set of features! Epub 2011 Oct 3.Tschida SJ, Guay DR, Straka RJ, Hoey LL, Johanning R, Vance-Bryan K.Pourmand A, Mazer-Amirshahi M, Chistov S, Sabha Y, Vukomanovic D, Almulhim M.Am J Emerg Med. ondansetron should be avoided in patients with congenital long QT syndrome caution must be used if administering ondansetron to patients with risk factors for QT interval prolongation … You are correct that there is a potentially serious interaction between Diflucan (fluconazole) and Zofran (ondansetron).Both can cause QT prolongation, an abnormal heart rhythm.QT prolongation increases the risk of serious cardiac conditions, such as Torsades de pointes, and ventricular fibrillation..
Contact your healthcare professional (e.g. Epub 2017 Aug 24.PLoS One. 2020 Apr;35(2):104-111. doi: 10.1016/j.jopan.2019.09.003.
2018 May;36(5):754-757. doi: 10.1016/j.ajem.2017.10.004. 5.2 QT Prolongation.
Methods: In a prospective observational study conducted at an urban academic medical center ED, a convenience sample of adult ED patients treated with ondansetron 4 mg i.v.
Ondansetron may cause a condition that affects the heart rhythm (QT prolongation).
were enrolled. A prospective, observational study in 40 cardiac patients (heart failure or ACS) found that ondansetron 4 mg… Ondansetron is the most frequently administered antiemetic in emergency medicine. Background Just like many other medications, ondansetron can prolong the QTc interval on an electrocardiogram.
This site needs JavaScript to work properly. Silverchair Information Systems Epub 2019 Sep 3. Conclusion: Significant QTc prolongation occurred in ED patients receiving a single 4-mg i.v.
Effect of Granisetron and Ondansetron on QTc interval Prolongation at various time intervals after administration [ Time Frame: 0 mins (before injection of study drug), 2 mins, 5 mins, 15mins, 1 hour and 2 hours ]
Clipboard, Search History, and several other advanced features are temporarily unavailable.
eCollection 2020.Cotteret C, Pham YV, Marcais A, Driessen M, Cisternino S, Schlatter J.BMC Pregnancy Childbirth. Unable to load your delegates due to an error
None of the patients had an ondansetron-related cardiac adverse event. 2020 Aug 27;15(8):e0237854. doi: 10.1371/journal.pone.0237854.
Answer.
2016 Jan;23(1):102-5. doi: 10.1111/acem.12836.
Moffett PM, Cartwright L, Grossart EA, O'Keefe D, Kang CS.Acad Emerg Med. In fact, the FDA released a Drug Safety Communication in 2012 recommending against IV doses > 16 mg to help limit the risk. Epub 2020 Jan 16.Cancer Chemother Pharmacol.
2011;3:53-8. doi: 10.2147/DHPS.S25623.
ECG changes including QT interval prolongation have been seen in patients receiving Zofran (ondansetron). Drugs with activity against the D2 receptor are often added as second-line agents (e.g., haloperidol, olanzapine, or prochlorperazine). 1 However, in September 2011 the Food and Drug Administration (FDA) issued a warning cautioning that ondansetron may increase the risk of fatal arrhythmias through prolongation of the QT …
Craig Cocchio, PharmD, BCPS, is an Emergency Medicine Clinical Pharmacist at Trinity Mother Frances Hospital in Tyler, Texas.
In addition, postmarketing cases of Torsade de Pointes have been reported in patients using ondansetron.